Sharon Bio-Medicine standalone net profit declines 48.37% in the September 2020 quarter

Sales rise 4.70% to Rs 41.89 crore

Net profit of Sharon Bio-Medicine declined 48.37% to Rs 2.37 crore in the quarter ended September 2020 as against Rs 4.59 crore during the previous quarter ended September 2019. Sales rose 4.70% to Rs 41.89 crore in the quarter ended September 2020 as against Rs 40.01 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales41.8940.01 5 OPM %11.1016.10 -PBDT5.256.93 -24 PBT2.374.59 -48 NP2.374.59 -48

Powered by Capital Market - Live News